Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Department of Midwifery, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Front Public Health. 2022 Jul 19;10:919494. doi: 10.3389/fpubh.2022.919494. eCollection 2022.
Vaccination is the best means of reducing the increased risk of severe COVID-19 during pregnancy. Data on COVID-19 vaccine uptake among pregnant women in Ethiopia is scarce. Thus, this study aimed to assess COVID-19 vaccine uptake and associated factors among pregnant women.
An institution-based cross-sectional study was conducted among 634 pregnant women attending antenatal care in Debre Tabor public health institutions from March 14 to 30, 2022. Participants were recruited using a multistage sampling technique and data were collected face-to-face interviews using a pre-tested structured questionnaire. Stata version 16.0 software was used for data analysis. Multiple logistic regression analysis was used to assess factors associated with COVID-19 vaccine uptake, with a p-value< 0.05 considered statistically significant.
Only 14.4% (95% CI: 11.7%-17.3%) of participants had received at least one dose of COVID-19 vaccines. The main reasons for declining vaccination were fear that the COVID-19 vaccine may have harmful side effects on the fetus or the mother. Being 45 or older (AOR: 1.75, 95%CI: 1.01-2.95), being married (AOR: 1.26, 95%CI: 1.12, 2.96), having good knowledge (AOR:3.52, 95%CI:1.83-3.87), and a positive attitude (AOR:4.81, 95% CI: 1.42-7.33) were positive predictors of COVID-19 vaccine uptake. But attaining a college or university education (AOR: 0.43, 95%CI: 0.12-0.69) was found to be a barrier to vaccine uptake by pregnant women.
COVID-19 vaccination among pregnant women was substantially low. Old age, being married, low education, good knowledge, and a positive attitude were significant predictors of COVID-19 vaccine uptake. To enhance the COVID-19 vaccine uptake, the government should improve the knowledge and attitude of pregnant women toward the COVID-19 vaccine.
接种疫苗是降低孕妇罹患 COVID-19 重症风险的最佳手段。关于埃塞俄比亚孕妇接种 COVID-19 疫苗的数据十分有限。因此,本研究旨在评估孕妇 COVID-19 疫苗接种率及其相关因素。
2022 年 3 月 14 日至 30 日,在德布雷塔博尔公共卫生机构接受产前护理的 634 名孕妇参与了一项基于机构的横断面研究。采用多阶段抽样技术招募参与者,并使用预先测试的结构化问卷进行面对面访谈收集数据。使用 Stata 版本 16.0 软件进行数据分析。采用多因素逻辑回归分析评估与 COVID-19 疫苗接种率相关的因素,p 值<0.05 被认为具有统计学意义。
仅有 14.4%(95%CI:11.7%-17.3%)的参与者接种了至少一剂 COVID-19 疫苗。拒绝接种疫苗的主要原因是担心 COVID-19 疫苗可能对胎儿或母亲产生有害的副作用。45 岁及以上(AOR:1.75,95%CI:1.01-2.95)、已婚(AOR:1.26,95%CI:1.12,2.96)、知识水平较好(AOR:3.52,95%CI:1.83-3.87)和积极的态度(AOR:4.81,95%CI:1.42-7.33)是 COVID-19 疫苗接种的积极预测因素。但获得大学或大学教育(AOR:0.43,95%CI:0.12-0.69)被认为是孕妇接种疫苗的障碍。
孕妇 COVID-19 疫苗接种率较低。年龄较大、已婚、低教育程度、良好的知识水平和积极的态度是 COVID-19 疫苗接种的显著预测因素。为提高 COVID-19 疫苗接种率,政府应提高孕妇对 COVID-19 疫苗的知识和态度。